News Announcement

Marksans Pharma: Shareholder Meeting / Postal Ballot-Outcome of AGM

The shareholders of the Company have at the 27th Annual General Meeting held on 26th September 2019:

1. Adopted the Standalone and Consolidated Audited Financial Statements of the Company for the financial year ended 31st March 2019 together with the reports of the Board of Directors and the Auditors thereon.

2. Declared dividend of Rs. 0.05 (i.e. 5%) on Equity Shares of Re. 1/- each face value and dividend of Rs. 7.00 (i.e. 7%) on Redeemable Cumulative Preference Shares of Rs. 100/- each face value. The dividend will be paid on or after 4rd October 2019.

3. Approved re-appointment of Mrs. Sandra Saldanha (DIN: 00021023) who retired by rotation and being eligible offered herself for re-appointment.

4. Approved appointment of Mr. Abhinna Sundar Mohanty (DIN: 00007995) as an Independent Director of the Company for a period of five (5) consecutive years with effect from 11th July 2019.

5. Approved Marksans Employees Stock Option Scheme 2019.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.